Investing $122,100 in These 3 High-Yield Dividend Stocks Could Make You $10,000 in Reliable Passive Income in 2026

Source Motley_fool

Key Points

  • Ares Capital offers an especially juicy dividend.

  • Energy Transfer has an impressive track record of increasing its distribution each quarter.

  • Pfizer has paid a dividend for 345 consecutive quarters.

  • 10 stocks we like better than Pfizer ›

According to the Chinese calendar, 2026 is the Year of the Fire Horse. With due apologies to fire horses across the world, I think income investors should go with a different moniker for the new year. What if we dub 2026 the Year of Making Reliable Passive Income?

It's quite possible for the new year to fulfill this ambitious name. Investing $122,100 in these three high-yield dividend stocks could make you $10,000 in reliable passive income in 2026.

Where to invest $1,000 right now? Our analyst team just revealed what they believe are the 10 best stocks to buy right now. Continue »

A smiling person with hand behind head and feet on a desk.

Image source: Getty Images.

1. Ares Capital

Let's assume we take one-third of the initial $122,100, which amounts to $40,700, and invest it in Ares Capital (NASDAQ: ARCC). Based on the stock's forward dividend yield of slightly above 9.5%, you should be able to receive roughly $3,875 in dividend income in 2026.

But is that dividend income reliable? I think so. For one thing, Ares Capital is the largest publicly traded business development company (BDC). To be exempt from paying federal income taxes, BDCs must return at least 90% of their income to shareholders as dividends.

Ares Capital has an impressive track record of paying dividends. The company has either grown or maintained its dividend for 65 consecutive quarters (16 years and counting).

The odds are also pretty good that you'll enjoy more than just dividend income with this stock. Ares Capital's total returns since its initial public offering in 2004 have trounced the S&P 500 (SNPINDEX: ^GSPC) and the S&P BDC Index.

2. Energy Transfer LP

Investing another one-third of the initial $122,100 in Energy Transfer LP (NYSE: ET) could also pay off handsomely. This limited partnership (LP) pays a distribution that yields nearly 8.2%. Energy Transfer could easily generate passive income of $3,325 in the new year.

I suspect the actual income total will be even higher, though. Energy Transfer has increased its distributions in every quarter since the third quarter of 2021. The midstream energy leader targets annual distribution growth of between 3% and 5%.

Can Energy Transfer achieve this growth target? I think so. The LP's financial position is the strongest in its history. Energy Transfer also has a manageable debt load and a comfortable distribution coverage ratio.

The financial numbers could improve in 2026. Energy Transfer has multiple agreements in place to supply natural gas to data centers operated by cloud giant Oracle (NYSE: ORCL) and other companies. It's also opening new natural gas processing plants and expanding pipelines in the new year.

3. Pfizer

Finally, buying $40,700 of Pfizer (NYSE: PFE) stock could add another $2,800 in passive income in 2026, thanks to the big drugmaker's forward dividend yield of around 6.9%. Adding this amount to the income generated from investing in Ares Capital and Energy Transfer brings our total to the $10,000 threshold.

Pfizer has increased its dividend for 16 consecutive years. The company has paid dividends for 345 consecutive quarters – an impressive 86-year streak.

There is an elephant in the room, though. Pfizer's growth has stagnated. The pharma giant projects 2026 revenue of between $59.5 billion and $62.5 billion. The midpoint of that guidance range is below the $62 billion revenue figure the company expects to generate in 2025.

One challenge for Pfizer is that its COVID-19 product revenue will likely be lower than originally forecast. Another is that the company faces a patent cliff, with several key products losing patent exclusivity over the next few years.

Will all of this affect Pfizer's dividend in 2026? I don't think so. Pfizer continues to generate solid free cash flow. Management has also consistently emphasized its commitment to maintaining and growing the dividend over time.

Should you buy stock in Pfizer right now?

Before you buy stock in Pfizer, consider this:

The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Pfizer wasn’t one of them. The 10 stocks that made the cut could produce monster returns in the coming years.

Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you’d have $505,749!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you’d have $1,149,658!*

Now, it’s worth noting Stock Advisor’s total average return is 979% — a market-crushing outperformance compared to 195% for the S&P 500. Don't miss the latest top 10 list, available with Stock Advisor, and join an investing community built by individual investors for individual investors.

See the 10 stocks »

*Stock Advisor returns as of January 1, 2026.

Keith Speights has positions in Ares Capital, Energy Transfer, and Pfizer. The Motley Fool has positions in and recommends Ares Capital, Oracle, and Pfizer. The Motley Fool has a disclosure policy.

Disclaimer: For information purposes only. Past performance is not indicative of future results.
placeholder
US Dollar's Decline Predicted in 2026: Morgan Stanley's Outlook on Currency VolatilityMorgan Stanley forecasts a 5% drop in the dollar by mid-2026, attributed to continued Fed rate cuts. A recovery may follow as growth improves and funding currency dynamics shift favorably toward the euro and Swiss franc.
Author  Mitrade
Nov 25, 2025
Morgan Stanley forecasts a 5% drop in the dollar by mid-2026, attributed to continued Fed rate cuts. A recovery may follow as growth improves and funding currency dynamics shift favorably toward the euro and Swiss franc.
placeholder
Gold's Historic 2025 Rally: Can the Momentum Last Through 2026?Following a historic surge in 2025 that saw prices climb over 60% and break records more than 50 times, gold investors are now looking ahead to assess whether the precious metal can sustain its momentum into 2026. Despite outperforming most major asset classes and heading for its best annual performance since 1979, analysts are divided on the outlook—with some seeing further room for gains and others cautioning that risks are rising.
Author  Mitrade
Dec 09, 2025
Following a historic surge in 2025 that saw prices climb over 60% and break records more than 50 times, gold investors are now looking ahead to assess whether the precious metal can sustain its momentum into 2026. Despite outperforming most major asset classes and heading for its best annual performance since 1979, analysts are divided on the outlook—with some seeing further room for gains and others cautioning that risks are rising.
placeholder
BOJ Set to Hike Rates Amid Inflation Pressures and Yen Weakness The Bank of Japan is expected to raise its benchmark interest rate to 0.75% on December 19, marking its first increase since early 2025, amidst ongoing inflation and a weakening yen. Analysts predict additional hikes in 2026 as the central bank navigates renewed monetary policy normalization under Governor Kazuo Ueda.
Author  Mitrade
Dec 18, 2025
The Bank of Japan is expected to raise its benchmark interest rate to 0.75% on December 19, marking its first increase since early 2025, amidst ongoing inflation and a weakening yen. Analysts predict additional hikes in 2026 as the central bank navigates renewed monetary policy normalization under Governor Kazuo Ueda.
placeholder
Gold Prices Hit Record High Amid U.S.-Venezuela Tensions and Rising Geopolitical RisksGold surged to an all-time high as safe-haven demand increased due to escalating tensions between the U.S. and Venezuela, with significant gains seen in other precious metals like silver and platinum.
Author  Mitrade
Dec 23, 2025
Gold surged to an all-time high as safe-haven demand increased due to escalating tensions between the U.S. and Venezuela, with significant gains seen in other precious metals like silver and platinum.
placeholder
Bitcoin Dips Below $88K Amid Low Trading Volumes and Waning Institutional Demand Bitcoin fell to $87,458, down 2.5% as it struggled to maintain momentum above $90,000. Diminished institutional demand and holiday-thinned trading conditions have led to increased caution among investors ahead of key Federal Reserve meeting minutes.
Author  Mitrade
Dec 30, 2025
Bitcoin fell to $87,458, down 2.5% as it struggled to maintain momentum above $90,000. Diminished institutional demand and holiday-thinned trading conditions have led to increased caution among investors ahead of key Federal Reserve meeting minutes.
goTop
quote